5	5	O	O	O	O
flourouracil-induced	flourouracil-induced	O	O	O	O
apical	apical	O	DISEASE	OTHERS	I
ballooning	ballooning	O	DISEASE	OTHERS	I
syndrome	syndrome	O	DISEASE	OTHERS	I
:	:	O	O	O	O
a	a	O	O	O	O
case	case	O	O	O	O
report	report	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
apical	apical	O	DISEASE	OTHERS	I
ballooning	ballooning	O	DISEASE	OTHERS	I
syndrome	syndrome	O	DISEASE	OTHERS	I
(	(	O	O	O	O
ABS	abs	O	O	OTHERS	I
)	)	O	O	O	O
is	is	O	O	O	O
a	a	O	O	O	O
recently	recently	O	O	O	O
described	described	O	O	O	O
stress-mediated	stress-mediated	O	O	O	O
acute	acute	O	O	OTHERS	I
cardiac	cardiac	O	O	OTHERS	I
syndrome	syndrome	O	O	OTHERS	I
characterized	characterized	O	O	O	O
by	by	O	O	O	O
transient	transient	O	O	O	O
wall-motion	wall-motion	O	O	O	O
abnormalities	abnormalities	O	O	O	O
involving	involving	O	O	O	O
the	the	O	O	O	O
apex	apex	O	O	O	O
and	and	O	O	O	O
midventricle	midventricle	O	O	O	O
with	with	O	O	O	O
hyperkinesis	hyperkinesis	O	O	OTHERS	I
of	of	O	O	O	O
the	the	O	O	O	O
basal	basal	O	O	O	O
left	left	O	O	O	O
ventricular	ventricular	O	O	O	O
(	(	O	O	O	O
LV	lv	O	O	OTHERS	I
)	)	O	O	O	O
segments	segments	O	O	O	O
without	without	O	O	O	O
obstructive	obstructive	O	O	O	O
epicardial	epicardial	O	O	OTHERS	I
coronary	coronary	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Cardiotoxicity	cardiotoxicity	O	DISEASE	OTHERS	I
is	is	O	O	O	O
not	not	O	O	O	O
an	an	O	O	O	O
uncommon	uncommon	O	O	O	O
adverse	adverse	O	O	O	O
effect	effect	O	O	O	O
of	of	O	O	O	O
chemotherapeutic	chemotherapeutic	O	O	O	O
agents	agents	O	O	O	O
.	.	O	O	O	O

However	however	O	O	O	O
,	,	O	O	O	O
there	there	O	O	O	O
are	are	O	O	O	O
no	no	O	O	O	O
reports	reports	O	O	O	O
of	of	O	O	O	O
ABS	abs	O	O	OTHERS	I
secondary	secondary	O	O	O	O
to	to	O	O	O	O
chemotherapeutic	chemotherapeutic	O	O	O	O
agents	agents	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
describe	describe	O	O	O	O
the	the	O	O	O	O
case	case	O	O	O	O
of	of	O	O	O	O
a	a	O	O	O	O
woman	woman	O	O	O	O
who	who	O	O	O	O
developed	developed	O	O	O	O
the	the	O	O	O	O
syndrome	syndrome	O	O	O	O
after	after	O	O	O	O
chemotherapy	chemotherapy	O	O	O	O
for	for	O	O	O	O
metastatic	metastatic	O	O	O	O
cancer	cancer	O	DISEASE	OTHERS	I
.	.	O	O	O	O

A	a	O	O	O	O
79-year-old	79-year-old	O	O	O	O
woman	woman	O	O	O	O
presented	presented	O	O	O	O
with	with	O	O	O	O
typical	typical	O	O	O	O
ischemic	ischemic	O	O	OTHERS	I
chest	chest	O	DISEASE	OTHERS	I
pain	pain	O	DISEASE	OTHERS	I
,	,	O	O	O	O
elevated	elevated	O	O	O	O
cardiac	cardiac	O	O	O	O
enzymes	enzymes	O	O	O	O
with	with	O	O	O	O
significant	significant	O	O	O	O
ST-segment	st-segment	O	O	O	O
abnormalities	abnormalities	O	O	O	O
on	on	O	O	O	O
her	her	O	O	O	O
electrocardiogram	electrocardiogram	O	O	O	O
.	.	O	O	O	O

She	she	O	O	O	O
underwent	underwent	O	O	O	O
recent	recent	O	O	O	O
chemotherapy	chemotherapy	O	O	O	O
with	with	O	O	O	O
fluorouracil	fluorouracil	O	O	OTHERS	I
for	for	O	O	O	O
metastatic	metastatic	O	O	O	O
colorectal	colorectal	O	O	OTHERS	I
cancer	cancer	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Echocardiography	echocardiography	O	O	O	O
revealed	revealed	O	O	O	O
a	a	O	O	O	O
wall-motion	wall-motion	O	O	O	O
abnormality	abnormality	O	O	O	O
involving	involving	O	O	O	O
the	the	O	O	O	O
apical	apical	O	O	O	O
and	and	O	O	O	O
periapical	periapical	O	O	O	O
segments	segments	O	O	O	O
which	which	O	O	O	O
appeared	appeared	O	O	O	O
akinetic	akinetic	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Coronary	coronary	O	O	O	O
angiography	angiography	O	O	O	O
revealed	revealed	O	O	O	O
no	no	O	O	O	O
obstructive	obstructive	O	O	O	O
coronary	coronary	O	O	O	O
lesions	lesions	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
patient	patient	O	O	O	O
was	was	O	O	O	O
stabilized	stabilized	O	O	O	O
with	with	O	O	O	O
medical	medical	O	O	O	O
therapy	therapy	O	O	O	O
.	.	O	O	O	O

Four	four	O	O	O	O
weeks	weeks	O	O	O	O
later	later	O	O	O	O
she	she	O	O	O	O
remained	remained	O	O	O	O
completely	completely	O	O	O	O
asymptomatic	asymptomatic	O	O	O	O
.	.	O	O	O	O

Echocardiogram	echocardiogram	O	O	O	O
revealed	revealed	O	O	O	O
a	a	O	O	O	O
normal	normal	O	O	O	O
ejection	ejection	O	O	O	O
fraction	fraction	O	O	O	O
and	and	O	O	O	O
a	a	O	O	O	O
resolution	resolution	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
apical	apical	O	O	O	O
akinesis	akinesis	O	O	OTHERS	I
.	.	O	O	O	O

Pathogenetic	pathogenetic	O	O	O	O
mechanisms	mechanisms	O	O	O	O
of	of	O	O	O	O
cardiac	cardiac	O	O	OTHERS	I
complications	complications	O	O	OTHERS	I
in	in	O	O	O	O
cancer	cancer	O	DISEASE	OTHERS	I
patients	patients	O	O	O	O
undergoing	undergoing	O	O	O	O
chemotherapy	chemotherapy	O	O	O	O
include	include	O	O	O	O
coronary	coronary	O	DISEASE	OTHERS	I
vasospasm	vasospasm	O	DISEASE	OTHERS	I
,	,	O	O	O	O
endothelial	endothelial	O	O	O	O
damage	damage	O	O	O	O
and	and	O	O	O	O
consequent	consequent	O	O	O	O
thrombus	thrombus	O	O	OTHERS	I
formation	formation	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
our	our	O	O	O	O
patient	patient	O	O	O	O
,	,	O	O	O	O
both	both	O	O	O	O
supraphysiologic	supraphysiologic	O	O	O	O
levels	levels	O	O	O	O
of	of	O	O	O	O
plasma	plasma	O	O	O	O
catecholamines	catecholamines	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
stress	stress	O	O	O	O
related	related	O	O	O	O
neuropeptides	neuropeptides	O	O	O	O
caused	caused	O	O	O	O
by	by	O	O	O	O
cancer	cancer	O	DISEASE	OTHERS	I
diagnosis	diagnosis	O	O	O	O
as	as	O	O	O	O
well	well	O	O	O	O
as	as	O	O	O	O
chemotherapy	chemotherapy	O	O	O	O
may	may	O	O	O	O
have	have	O	O	O	O
contributed	contributed	O	O	O	O
the	the	O	O	O	O
development	development	O	O	O	O
of	of	O	O	O	O
ABS	abs	O	O	OTHERS	I
.	.	O	O	O	O

